Answers are grounded in this paper and cite their sources.
Introduction There has been considerable interest in the prognostic utility of circulating tumour cell (CTC) counts in oncology research in recent years [1-4]. Early research was directed at the use of circulating tumour cell counts as a variable prognostic for disease progression, progression-free survival, or overall
No takes yet. Share an insight, caveat, or question.
Cotton et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: